High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

Item
http://www.wikidata.org/entity/Q27498879
Cold-inducible proteins CIRP and RBM3, a unique couple with activities far beyond the coldRNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection.High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas.Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report.Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma.ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.Lack of SF3B1 R625 mutations in cutaneous melanoma.Construction and analysis of multiparameter prognostic models for melanoma outcomePodocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.Cultivation-dependent plasticity of melanoma phenotype.Ki-67 protein predicts survival in oral squamous carcinoma cells: an immunohistochemical study.Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer.Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study.Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach.Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
P2860

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

Item
http://www.wikidata.org/entity/Q27498879
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@ast
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@en
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@nl
type
label
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@ast
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@en
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@nl
prefLabel
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@ast
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@en
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P3181
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P3181
P356
P1433
P1476
High MCM3 expression is an ind ...... e cohort of malignant melanoma
@en
P2093
P2860
P2888
P304
P31
P3181
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932